These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 32481261)
21. Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali. Keita A; Sereme Y; Pillet S; Coulibaly S; Diallo F; Pozzetto B; Thiero TA; Bourlet T J Antimicrob Chemother; 2019 Jan; 74(1):165-171. PubMed ID: 30285106 [TBL] [Abstract][Full Text] [Related]
22. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania. Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277 [TBL] [Abstract][Full Text] [Related]
23. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A; Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566 [TBL] [Abstract][Full Text] [Related]
24. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Viani RM; Araneta MR; Deville JG; Spector SA Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789 [TBL] [Abstract][Full Text] [Related]
25. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women. Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM; J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340 [TBL] [Abstract][Full Text] [Related]
26. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235 [TBL] [Abstract][Full Text] [Related]
27. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study. Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857 [TBL] [Abstract][Full Text] [Related]
28. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126 [TBL] [Abstract][Full Text] [Related]
29. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy. Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO mBio; 2021 Mar; 12(2):. PubMed ID: 33688002 [TBL] [Abstract][Full Text] [Related]
30. The next generation: Pregnancy in adolescents and women living with perinatally acquired HIV in South Africa. Anderson K; Mutemaringa T; Technau KG; Johnson LF; Braithwaite K; Mokotoane E; Boulle A; Davies On Behalf Of IeDEA-Sa Pediatrics MA S Afr Med J; 2021 Mar; 111(3):260-264. PubMed ID: 33944749 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients. Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa. De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246 [TBL] [Abstract][Full Text] [Related]
34. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012. Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D; AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124 [TBL] [Abstract][Full Text] [Related]
35. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
36. Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. Hamers RL; Schuurman R; Sigaloff KC; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Wit FW; van Vugt M; Stevens WS; de Wit TF; Lancet Infect Dis; 2012 Apr; 12(4):307-17. PubMed ID: 22036233 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV. Frigati L; Mahtab S; Nourse P; Ray P; Perrazzo S; Machemedze T; Agyei NA; Cotton M; Myer L; Zar H Pediatr Nephrol; 2019 Feb; 34(2):313-318. PubMed ID: 30219929 [TBL] [Abstract][Full Text] [Related]
38. Oral lactoferrin in HIV-1 vertically infected children: an observational follow-up of plasma viral load and immune parameters. Zuccotti GV; Salvini F; Riva E; Agostoni C J Int Med Res; 2006; 34(1):88-94. PubMed ID: 16604828 [TBL] [Abstract][Full Text] [Related]
39. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA). AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161 [TBL] [Abstract][Full Text] [Related]
40. Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus. Sölder B; Wintergerst U; Notheis G; Eberle J; Gürtler L; Belohradsky BH J Pediatr; 1997 Feb; 130(2):293-9. PubMed ID: 9042135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]